16:50 EDT Lenz Therapeutics (LENZ) files to sell 13.07M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LENZ:
- Lenz Therapeutics’ Earnings Call Highlights Positive Outlook
- Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid Strong Market Position and Upcoming Product Launch
- Lenz Therapeutics price target raised to $38 from $37 at BofA
- LENZ Therapeutics: Innovative Presbyopia Treatment and Strategic Growth Reinforce Buy Rating
- Promising Outlook for LENZ Therapeutics: Buy Rating Backed by Strategic Marketing and Anticipated FDA Approval